Fluoxetine has neuroprotective effects after cardiac arrest and cardiopulmonary resuscitation in mouse

Resuscitation

Volumn 83, Issue 5, 2012, Pages 652-656

  Taguchi, Noriko ^a   Nakayama, Shin ^a   Tanaka, Makoto ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Cardiac arrest; Fluoxetine; Neuroprotection

Indexed keywords

FLUOXETINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG MEGADOSE; HEART ARREST; HIPPOCAMPUS; HISTOPATHOLOGY; LOW DRUG DOSE; MALE; MOUSE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; RESUSCITATION; SENSORIMOTOR FUNCTION;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CARDIOPULMONARY RESUSCITATION; FLUOXETINE; HEART ARREST; MALE; MICE; NEUROPROTECTIVE AGENTS; SEROTONIN UPTAKE INHIBITORS;

EID: 84859967377     PISSN: 03009572     EISSN: 18731570     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2011.11.004     Document Type: Article

References (25)

1. De Vreede-Swagemakers J.J., Gorgels A.P., Dubois-Arbouw W.I., et al. Out-of-hospital cardiac arrest in the 1990s: a population-based study in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol 1997, 30:1500-1505.
2. Lim C., Alexander M.P., LaFleche G., Schnyer D.M., Verfaellie M. The neurological and cognitive sequelae of cardiac arrest. Neurology 2004, 30:1774-1778.
3. Van Alem A.P., de Vos R., Schmand B., Koster R.W. Cognitive impairment in survivors of out-of hospital cardiac arrest. Am Heart J 2004, 148:416-421.
4. D'sa C., Duman R.S. Antidepressants and neuroplasticity. Bipolar Disord 2002, 3:183-194.
5. Santarelli L., Saxe M., Gross C., et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003, 301:805-809.
6. Lim C.M., Kim S.W., Park J.Y., Kim C., Yoon S.H., Lee J.K. Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect. J Neurosci Res 2009, 87:1037-1045.
7. Kofler J., Hattori K., Sawada M., et al. Histopathological and behavior characterization of a novel model of cardiac arrest and cardiopulmonary resuscitation in mice. J Neurosci Methods 2004, 136:33-44.
8. Ruediger R.N., Kofler J., Hurn P.D., Traystman R.J. Dose-dependent neuroprotection by 17β-estradiol after cardiac arrest and cardiopulmonary resuscitation. Crit Care Med 2005, 33:1595-1602.
9. Nakano T., Hurn P.D., Herson P.S., Traystman R.J. Testosterone exacerbates neuronal damage following cardiac arrest and cardiopulmonary resuscitation in mouse. Brain Res 2010, 1357:124-130.
10. 2 inhalation affects potassium levels in mice. J Am Assoc Lab Anim Sci 2010, 49:316-322.
11. Pariente J., Loubinoux I., Carel C., et al. Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann Neurol 2001, 50:718-729.
12. Shin T.K., Kang M.S., Lee H.Y., et al. Fluoxetine and sertraline attenuate postischemic brain injury in mice. Korean J Physiol Pharmacol 2009, 13:257-263.
13. Zhao C.S., Puurunen K., Schallert T., Sivenius J., Jolkkonen J. Behavioral and histological effects of chronic antipsychotic and antidepressant drug treatment in aged rats with focal ischemic brain injury. Behav Brain Res 2005, 158:211-220.
14. Jolkkonen J., Puurunen K., Rantakomi S., Sirvio J., Haapalinna A., Sivenius J. Effect of fluoxetine on sensorimotor and spatial learning deficits following focal cerebral ischemia in rats. Restor Neurol Neurosci 2000, 17:211-216.
15. Windle V., Corbett D. Fluoxetine and recovery of motor function after focal ischemia in rats. Brain Res 2005, 1044:25-32.
16. Kim D.H., Li H., Yoo K.Y., Lee B.H., Hwang I.K., Won M.H. Effects of fluoxetine in ischemic cells and expressions in BDNF and some antioxidants in the gerbil hippocampal CA1 region induced by transient ischemia. Exp Neurol 2007, 204:748-758.
17. Adrie C., Adib-Conquy M., Laurent I., et al. Successful cardiopulmonary resuscitation after cardiac arrest as a " sepsis-like" syndrome. Circulation 2002, 106:562-568.
18. Roumestan C., Michael A., Bichon F. Anti-inflammatory properties of desipramine and fluoxetine. Respir Res 2007, 8:35-45.
19. Higashi T., Nagura Y., Shimada K., Toyo'oka T. Studies on neurosteroids XXVI. Fluoxetine-evoked changes in rat brain and serum levels of neuroactive androgen, 5α-androstane-3 α, 17β-diol. Biol Pharm Bull 2009, 32:1636-1638.
20. Kelly M.H., Taguchi N., Adreshiri A., et al. Ischemic insult to cerebral Purkinje cells causes diminished GABAA receptor function and allopregnanolone neuroprotection in associated with GABAA receptor stabilization. J Neurochem 2008, 107:668-678.
21. Sanders R.D., Ma D., Maze M. Anesthesia induced neuroprotection. Best Pract Res Clin Anaesthesiol 2005, 19:461-474.
22. Sheng H., Laskowitz D.T., Pearlstein R.D., Warner D.S. Characterization of a recovery global cerebral ischemia model in the mouse. J Neurosci Methods 1999, 88:103-109.
23. Kawaguchi M., Kimbro J.R., Drummond J.C., Cole D.J., Kelly P.J., Patel P.M. Isoflurane delays but does not prevent cerebral infarction in rats subjected to focal ischemia. Anesthesiology 2000, 92:1335-1342.
24. Karmarkar S.W., Bottum K.M., Tischkau S.A. Considerations for the use of anesthetics in neurotoxicity studies. Comp Med 2010, 60:256-262.
25. Chollet F., Tardy J., Albucher J.F., et al. Fluoxetine for motor recovery after acute ischemic stroke (FLAME): a randomized placebo-controlled trial. Lancet Neurol 2011, 10:123-130.